ERGYPAINE
Food supplement declared in France, declaration No 2017-12-119, decision dated 4 December 2017
ERGYPAINE is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- LABORATOIRE NUTERGIA
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 4 gélules par jour
- Directions for use
- 1 à 4 gélules par jour
- Objectives stated by the manufacturer (these are not authorised claims)
- Minceur / Brûleur
Declaration 152565, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Carica papaya L. | Fruit | Poudre (de plantes séchées ou broyées) | 200 mg |
| Ananas comosus (L.) Merrill | Fruit | Poudre (de plantes séchées ou broyées) | 140 mg |
| Vitis vinifera L. | Fruit | Extrait sec aqueux | 80 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Bromélaïne | not declared |
Additives
E470b
Other ingredients
Gélatine de poisson
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging
Label warnings
DJR = dose journalière recommandée maximale. Avis d'un professionnel de santé recommandé pour les enfants, en cas de grossesse et d'allaitement.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.